# Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee

> **NCT00137410** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 200 (—)

## Conditions studied

- Osteoarthritis,Knee

## Interventions

- **DRUG:** Celebrex

## Key facts

- **NCT ID:** NCT00137410
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 200 (—)
- **Last updated:** 2008-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00137410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00137410, "Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00137410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*